Source: Breathe, 16 (2) 200018; 10.1183/20734735.0018-2020
Disease area: Interstitial lung diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Elena Salvaterra, Ilaria Campo. Pulmonary alveolar proteinosis: from classification to therapy. Breathe, 16 (2) 200018; 10.1183/20734735.0018-2020

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary alveolar proteinosis Source: Eur Respir Rev 2011; 20: 98-107 Year: 2011 Pulmonary alveolar proteinosis Source: Eur Respir Mon; 2009: 46: 208–224 Year: 2009 Pulmonary alveolar proteinosis: report of two cases Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Lung cysts in pulmonary alveolar proteinosis. Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Our cases with pulmonary alveolar proteinosis Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis Source: International Congress 2019 – CCC Airway diseases Year: 2019 Pulmonary alveolar proteinosis Source: Respipedia Article Year: 2017 Pulmonary alveolar proteinosis and GMSCF antibodies: a case series Source: Eur Respir J 2004; 24: Suppl. 48, 670s Year: 2004 Pulmonary alveolar proteinosis, study of 29 cases Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Pulmonary alveolar proteinosis and GM/CSF antibodies Source: Eur Respir J 2005; 26: Suppl. 49, 30s Year: 2005 PAS-negative pulmonary alveolar proteinosis Source: Annual Congress 2008 - Rare clinical cases Year: 2008 Pulmonary alveolar proteinosis: A case report Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms Year: 2013 Alveolar proteinosis Source: Annual Congress 2004 - Update on rare diffuse lung diseases Year: 2004 Pulmonary alveolar proteinosis therapy success with combined lavage procedures: a case report Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Pulmonary alveolar proteinosis (PAP) - clinical features and response to treatment by bronchofiberoscopic lobar lavage Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005 Treatment of severe pulmonary alveolar proteinosis using inhaled GM-CSF Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Pulmonary alveolar proteinosis and long-term outcome after bronchopulmonary lavage Source: International Congress 2017 – Paediatric bronchology Year: 2017